Atrial fibrillation - new aspects on mechanism and treatment

Journal of Internal Medicine

Volumn 239, Issue 1, 1996, Pages 3-15

  Olsson, S Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL; WARFARIN;

COMPLICATION; ELECTROPHYSIOLOGY; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030048285     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.357688000.x     Document Type: Review

References (43)

1. Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994.
2. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustained arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70.
3. Allessie MA, Lammers WJEP, Bonke FIM, Hollen J. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology and Arrhythmias. Orlando: Grune and Stratton, 1985; 265-76.
4. DeLangen CDJ, van den Berg MP, Haaksma J, Crijns HJGM, Dijk WA, Lie KI. Autocorrelation of AA intervals in artificially induced atrial fibrillation in the porcine heart. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation. Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 187-94.
5. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie AA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. 1995 (in press).
6. Cosio FG. Intra-atrial conduction and atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 51-66.
7. Michelucci A, Padeletti L, Porciani MC, Mezzani A, Salvi S, Bamoshmoosh M, Gensini GF. Dispersion of refractoriness and atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 81-108.
8. Franz MR. The role of monophasic action potential recording in atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 109-26.
9. Konings KTS, Kirchhof CJHJ, Smeets JRLM, Wellens HJJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89: 1665-80.
10. Holm M, Blomström P, Brandt J, Johansson R, Lührs C, Olsson SB. Determination of preferable directions of impulse propagation during atrial fibrillation by time averaging of multiple electrogram vectors. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 67-80.
11. Waldo AL, MacLean WAH, Cooper TB, Kouchoukos NT, Karp RB. The use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open heart surgery. J Thorac Cardiovasc Surg 1978; 76: 500-505.
12. Wells JL Jr, Karp RB, Kouchoukos NT, MacLean WAH, James TN et al. Characterization of atrial fibrillation in man: studies following open heart surgery. PACE 1978; 1: 426-38.
13. Janse MJ, van Capelle FJL, Anderson RH et al. Electrophysiology and structure of the atrioventricular node of the isolated rabbit heart. In: Wellens HJJ, Lie KI, Janses MJ, eds. The Conduction System of the Heart. Keiden: Stenfert Kroese, 1976; 296.
14. Olsson SB, Cai N, Donnai M, Tal war KK. Noninvasive support for and characterisation of multiple intranodal pathways in patients with mitral valve disease and atrial fibrillation. Eur Heart J 1986; 7: 320-33.
15. Coumel P, Attuel P, Lavallée JP et al. Syndrome d'arythmie auriculaire d'origine vagale. Arch Mal Coeur 1978; 71: 645.
16. Furlanello F, Bertoldi A, Dallago M, Vergara G, Biffi A, Fernando F, Caselli G. Atrial fibrillation in top-level athletes. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 203-10.
17. Koskinen P. Alcohol consumption and supraventricular tachyarrhythmias: a clinical study in young and middle-aged patients. Thesis. Helsinki: Yliopistopaino 1991.
18. Schlepper M. Identification of patients with atrial fibrillation at risk for thromboembolism. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 15-24.
19. Virchow R. Plogose und thrombose im Gefäss-system. Gesamelte Abhandlungen zur wissenschaftlichen Medicin. Medinger, Son and Co. Frankfurt, 1856.
20. Engel TR, Bush CA, Schael SF. Tachycardia aggravated heart disease. Ann Intern Med 1974; 80: 384-8.
21. McLaren CJ, Gersh BT, Sugrue DD, Hammil SC, Seward JB et al. Tachycardia-induced myocardial dysfunction: a reversible phenomenon? Br Heart J 1985; 53: 323-7.
22. Wellens HJJ, Rodriguez LM, Smeets JLRM, Cheriex EC, Pieters F, den Dulk K. Tachycardiomyopathi in patients with supraventricular tachycardia with emphasis on atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 333-42.
23. Godtfredsen J. The role of aspirin and oral anticoagulant therapy in chronic atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 25-35.
24. Vaughan-Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 4: 129-47.
25. Campbell RWF. Atrial Fibrillation: Management with class Ic drugs. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 273-86.
26. Kottkamp H, Haverkamp W, Borggrefe M, Breithardt G. The role of "class III" antiarrhythmic drugs in atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 287-306.
27. Gold RL, Haffajee CI, Charos G et al. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986; 57: 124.
28. Horowitz LN, Spielman SR, Greenspan AM et al. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 1985; 6: 1402.
29. Brodsky MA, Allen BJ, Walker CJ et al. Amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation in the setting of a dilated left atrium. Am J Cardiol 1987; 60: 572.
30. Björk U, Karesoja M, Hirvonen P. Elective cardioversion in the elderly. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 343-8.
31. Touboul P, Canu G, Claudel P, Moncada E, Kirkorian G. His bundle ablation for atrial fibrillation: indications and results. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 307-24.
32. Rosenquist M. Cardiac pacing in atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 237-50.
33. Wittkampf FHM, de Jongste MJL, Lie HI, Meijler FL. Effect of right ventricular pacing on ventricular rhythm during atrial fibrillation. J Am Coll Cardiol 1988; 11: 539-45.
34. Lau CP, Leung WH, Wong CK, Tai YT, Cheng CH. A new pacing method for rapid regularization and rate control in atrial fibrillation. Am J Cardiol 1990; 65: 1198-203.
35. Alboni P, Paparella N. Pharmacological therapy of symtomatic atrial fibrillation with a slow ventricular response. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 157-70.
36. Cooper RAS, Ideker RE. Internal cardioversion of atrial fibrillation in sheep. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 325-32.
37. Murgatroyd F, Slade A, Kishore R, Anderson M, Rowland E, Ward D, Camm J. Safety and efficacy of low-energy transvenous cardioversion for atrial fibrillation of short duration (Abstract). European Heart Journal 1994: 15 Suppl.: 294.
38. Guiraudon GM, Campbell CS, Jones DL et al. Combined sinoatrial node atrioventricular isolation: a surgical alternative to His bundle ablation in patients with atrial fibrillation (Abstract). Circulation 1985; 72 (II:III): 220.
39. Cox JL, Boineau JP, Schuessler RB, Ferguson TB Jr, Cain ME et al. Successful surgical treatment of atrial fibrillation. J Am Med Assoc 1991; 266: 1976-80.
40. Kirchhof CJHJ, Wijffels CEF, Allessie MA. Pace-Termination of Atrial Fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation, Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co., 1994; 251-72.
41. Daubert C, Mabo Ph, Berder V, Gras D, Leclercq C. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronisation. European Journal of Cardiac Pacing and Electrophysiology 1994; 4 (No. 1): 35-44.
42. Olsson SB. Nature of cardiac arrhythmias and electrolyte disturbances. Role of potassium in atrial fibrillation. Acta Med Scand 1981; Suppl. 647: 33-37.
43. Swartz JF, Pellersels G, Silvers J, Patten L, Cervantez D. A catheter-based curative approach to atrial fibrillation in humans. Circulation 1994; 90 (No. 4, Part 2): I-335.